VIR - Vir Biotechnology, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$21.14
DETAILS
HIGH:
$30.00
LOW:
$18.00
MEDIAN:
$20.00
CONSENSUS:
$21.14
UPSIDE:
130.03%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 82.9% |
| EBIT Margin | -638.6% |
| EBITDA Margin | -621.5% |
| Operating Margin | -682.7% |
| Pretax Margin | -638.6% |
| Cont. Ops Margin | -638.9% |
| Net Margin | -638.9% |
| Bottom Line Margin | -638.9% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 5.54 |
| Quick Ratio | 5.54 |
| Solvency Ratio | -1.795 |
| Cash Ratio | 2.52 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings | |
| PEG Ratio | 0.11 |
| Forward PEG | 0.11 |
| Price/Book | 1.09 |
| Price/Sales | 12.18 |
| Price/FCF | -2.11 |
| Price/Op Cash Flow | -2.13 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.1864 |
| Debt/Equity | 0.2442 |
| Debt/Capital | 0.1963 |
| Long-Term Debt/Capital | 0.1042 |
| Financial Leverage | 1.31 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.10 |
| Operating Cash Flow Ratio | -4.221 |
| Operating Cash Flow/Sales | -571.5% |
| Free Cash Flow/Operating Cash Flow | 101.2% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -48.45 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -44.53 |
| Operating Cash Flow Coverage | -2.10 |
| Capital Expenditure Coverage | -81.08 |
| Dividend + Capital Expenditure Coverage | -81.08 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.49 |
| EPS | -3.162 |
| Debt/Share | 1.3493 |
| Cash/Share | 3.34 |
| Book Value/Share | 5.52 |
| Tangible BV/Share | 5.35 |
| Equity/Share | 5.52 |
| Operating Cash Flow/Share | -2.828 |
| Capital Expenditure/Share | 0.035 |
| FCF/Share | -2.863 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.935 |
| Price/Fair Value | 1.09 |
| Debt/Market Cap | 0.1171 |
| Effective Tax Rate | -0.0% |
| Enterprise Value Multiple | -1.85 |